Mexiletine (NaMuscla) for the treatment of myotonia in non-dystrophic myotonic disorders (2020)

First Author: Suetterlin K
Attributed to:  Progressive Muscular Weakness in Periodic Paralysis and Normal Ageing funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1080/21678707.2020.1739519

Publication URI: http://dx.doi.org/10.1080/21678707.2020.1739519

Type: Journal Article/Review

Parent Publication: Expert Opinion on Orphan Drugs

Issue: 2-3